Chemical Research in Toxicology· 2025Q1
From Toxicity Assessment to In Vivo Validation: Exploring the Molecular Mechanisms of Triclosan-Induced Liver Injury
- 32citations
- Q1SCImago
- 2025year
Short summary
This study reveals that triclosan (TCS) causes liver injury in piglets by inducing oxidative stress and activating specific signaling pathways (Rap1-PI3K/AKT, HIF-1/VEGF, Ras-MAPK), identified through network toxicology and validated in vivo.
AI-generated from the title and abstract; the full text is not read.
Key points
- Identified 31 major targets linked to triclosan (TCS)-induced liver injury.
- Molecular docking confirmed strong binding of TCS to the top 10 core targets.
- In vivo experiments showed TCS exposure caused liver damage and disrupted redox homeostasis in piglets.
- TCS significantly activated Rap1-PI3K/AKT, HIF-1/VEGF, and Ras-MAPK signaling pathways.
AI-generated from the title and abstract; the full text is not read.
Abstract
Triclosan (TCS), a synthetic compound initially marketed as a broad-spectrum antibacterial agent, poses significant threats to the environment, animal, and human health due to its inherent toxicity and improper discharge. This study first comprehensively assessed the environmental and biological toxicity of TCS. Subsequently, an integrated approach combining network toxicology, molecular docking, and in vivo experiments was employed to analyze and experimentally validate. For the first time, the mechanisms underlying TCS-induced liver injury in weaned piglets. Results identified 31 major targets associated with TCS-induced liver injury. Molecular docking confirmed strong binding affinity between TCS and the top 10 MCC-ranked core targets. Factor-gene and miRNA-gene regulatory networks were constructed for these core targets. Further GO and KEGG analyses revealed significant enrichment of TCS hepatotoxicity targets in biological processes, including redox regulation, and multiple signaling pathways. Validation via in vivo experiments in weaned piglets demonstrated that TCS exposure significantly induced liver damage and histopathological alterations. It disrupted hepatic redox homeostasis, evidenced by significantly decreased T-AOC, SOD, CAT, and GSH levels, alongside increased MDA levels. Furthermore, TCS significantly upregulated the expression of the Rap1-PI3K/AKT, HIF-1/VEGF, and Ras-MAPK signaling pathways. This study provides the first evidence that TCS exerts hepatotoxicity by inducing hepatic oxidative stress and aberrant activation of multiple signaling pathways. The findings offer novel data for the comprehensive toxicological assessment of TCS, contribute to safeguarding animal and human health, and propose a framework for the integrated risk assessment of similar environmental contaminants.
The authors' abstract, as published at the source. Chemical Research in Toxicology, 2025 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Pharmacology (Pharmacology, Toxicology and Pharmaceutics)
PharmacologyPharmacology, Toxicology and Pharmaceutics